Skip to main content

James F. Polewaczyk

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About James F. Polewaczyk

Idexx Laboratories Inc /De reported in an 8-K filed May 10, 2024 that James F. Polewaczyk retired as Executive Vice President, effective April 1, 2024. Idexx Laboratories Inc /De reported in an 8-K filed December 7, 2023 that James F. Polewaczyk retired as Executive Vice President and Chief Commercial Officer, effective April 1, 2024. The proxy statement of Idexx Laboratories Inc /De reports total compensation of $2,917,036 for James F. Polewaczyk in fiscal 2023, including a base salary of $559,154. Disclosed compensation is on record for 6 fiscal years.

“Mr. Polewaczyk was an Executive Vice President of the Company who retired effective April 1, 2024.”
Idexx Laboratories Inc /De Form 8-K, filed May 10, 2024 · Read the filing
“On December 5, 2023, James F. Polewaczyk, Executive Vice President and Chief Commercial Officer of IDEXX Laboratories, Inc. (the “Company”), notified the Company of his intent to retire after more than 17 years of dedicated leadership and service, effective April 1, 2024.”
Idexx Laboratories Inc /De Form 8-K, filed December 7, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Idexx Laboratories Inc /De (IDXX) $559,154 $2,917,036
2022 Idexx Laboratories Inc /De (IDXX) $538,327 $2,540,086
2021 Idexx Laboratories Inc /De (IDXX) $521,154 $2,592,975
2020 Idexx Laboratories Inc /De (IDXX) $486,461 $2,105,700
2019 Idexx Laboratories Inc /De (IDXX) — —
2018 Idexx Laboratories Inc /De (IDXX) — —

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.